Evolutionary Biology | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Related Articles
Skin of Color Savvy: News Update—SOCS Awards, My Best Winter Skin, & TORPEDO Program
The January 15, 2025 SOCS News Update highlights research ongoing/upcoming initiatives and awards, the My Best Winter Skin Campaign, and the TORPEDO program.
Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors
The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.
FBI: North Korean IT workers steal source code to extort employers
The FBI warned today that North Korean IT workers are abusing their access to steal source code and extort U.S. companies that have been tricked…
Elon Musk email to X staff: ‘we’re barely breaking even’
User growth is ‘stagnant’ on the platform formerly known as Twitter.
Healey warns electricity costs in Mass. will increase by $200 million under Trump tariffs
The governor said she is very concerned about the president’s idea to impose higher tariffs on China and new, steep tariffs on products imported from…
FTC Settles With Private Equity Firm Over Anesthesia Investments
‘We consider this a definite victory,’ physician says
Mayo Clinic Q and A: Living kidney donation can start a chain reaction – Mayo Clinic News Network
Have you considered being a living organ donor? A living kidney donation can start a chain reaction, helping multiple people. Learn more.
The 9 most powerful supercomputers in the world right now
Supercomputers play a vital role in scientific discoveries — from helping us forecast climate change to discovering new drugs. We’ve rounded up the top fastest…
Trump’s restrictions spark chaos across health and science agencies
The Trump administration’s freeze on communications, travel, and diversity efforts has sowed chaos across federal health agencies.
Obesity Medications: Who Needs Priority Access
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
